Injury clinical trials
Showing 51–68 of 68 active trials. Describe your situation to see which ones you may be eligible for.
- PRevention Of Trauma-related Infections Through an Embedded Clinical Trials Network
- Trans STAIR: Implementing an Evidence Based Trauma Treatment With Community Led PrEP Navigation
- Early Intervention to Prevent Development of PTSD in Burn Survivors and Their Caregivers
- Litter Packaging in the Lateral Position: Effects of Position and Vacuum Mattress Packaging on Pulmonary Function
- Cryo-FIRST: Effectiveness of INTERCEPT Fibrinogen Complex (IFC) for Trauma-Associated Hemorrhage
- Self-directed Mobile Mindfulness to Address ICU Survivors' Psychological Distress: the Lift RCT
- Use of Equity Report Cards to Mitigate Disparities in Emergency Medical Services (EMS) Care for Injured Children
- Transforming Research and Clinical Knowledge in Spinal Cord Injury
- Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism
- Reducing G60 Recidivism Rates
- Adult Trauma Centers RE-AIM at Gun Safety
- Trauma-Informed Obstetric Care: Development and Implementation of a Toolkit for Obstetrics (OBTIC)
- Sympathetic Activity in Post-injury Outcomes: Impact on Sleep and caRdiovascular Health InvesTigation
- Clinical Registry Collecting Real World Evidence on Wound Care Treatments
- MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
- Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention
- Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
- Community-based Partnership's Efficacy in Decreasing Injury Rates At Night in Dallas, TX
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.